Готові списки джерел за темами / Diabetes in India

Добірка наукової літератури з теми "Diabetes in India"

Автор: Grafiati
Опубліковано: 6 вересня 2023

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Зміст

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Diabetes in India".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Статті в журналах з теми "Diabetes in India"

1

Das, Ashok Kumar, Viswanathan Mohan, Ambady Ramachandran, Sanjay Kalra, Ambrish Mithal, Rakesh Sahay, Mangesh Tiwaskar, et al. "An Expert Group Consensus Statement on “Approach and Management of Prediabetes in India”." Journal of the Association of Physicians of India 70, no. 12 (December 1, 2022): 69–78. http://dx.doi.org/10.5005/japi-11001-0162.

Повний текст джерела
Анотація:
The prevalence of prediabetes, a forerunner of diabetes is very high, and its conversion to diabetes is also more rapid among Asian Indians. Prediabetes also predisposes to the development of macrovascular and to a lesser extent of microvascular complications of diabetes. In a large community-based epidemiological study, the Indian Council of Medical Research–India Diabetes (ICMR–INDIAB), data reported an overall prevalence of prediabetes of 10.3%, derived from 15 Indian states. This shows that the diabetes epidemic is far from over as many of them may soon convert to diabetes. Prediabetes, however, should not be considered a path to diabetes rather it should be a window of opportunity for the prevention of diabetes. This early screening, detection, and treatment of prediabetes should be made a national priority. Several countries have introduced lifestyle programs to prevent diabetes and, when indicated, pharmacological intervention with metformin as well. This consensus statement outlines the approaches to screening and lifestyle and pharmacological management of prediabetes in Asian Indians.
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Shah, Viral N., and Viswanathan Mohan. "Diabetes in India." Current Opinion in Endocrinology & Diabetes and Obesity 22, no. 4 (August 2015): 283–89. http://dx.doi.org/10.1097/med.0000000000000166.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Diamond, Jared. "Diabetes in India." Nature 469, no. 7331 (January 2011): 478–79. http://dx.doi.org/10.1038/469478a.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Mohan, V., T. Kaur, M. Deepa, A. Bhansali, RM Anjana, R. Pradeepa, SR Joshi, et al. "Knowledge and awareness of diabetes in urban and rural India: The Indian Council of Medical Research India Diabetes Study (Phase I): Indian Council of Medical Research India Diabetes 4." Indian Journal of Endocrinology and Metabolism 18, no. 3 (2014): 379. http://dx.doi.org/10.4103/2230-8210.131191.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Singh, U. "Prevalence of diabetes and other health related problems across India and worldwide: An overview." Journal of Applied and Natural Science 8, no. 1 (March 1, 2016): 500–505. http://dx.doi.org/10.31018/jans.v8i1.825.

Повний текст джерела
Анотація:
Diabetes mellitus is a major source of mortality and morbidity along with an economic menace all over the world. In 2000, prevalence of diabetes worldwide was 171,000,000 and in 2030, it will be 366,000,000, nearly one in ten people globally will have some form of diabetes by 2035. There are some 382 million people living with the disease, but that could jump 55% by 2035. The total number of people in India with diabetes to be around 50.8 million in 2010, rising to 87.0 million by 2030 and it is estimated that by 2040 the numbers will increase upto 123.5 million. It has estimated that the prevalence of diabetes in rural populations is one-quarter that of urban population for India and other Indian sub-continent countries such as Bangladesh, Nepal, Bhutan, and Sri Lanka. Indian Council of Medical research (ICMR) revealed that a lower proportion of the population is affected in states of Northern India (Chandigarh 0.12 million, Jharkhand 0.96 million) as compared to Maharashtra (9.2 million) and Tamil Nadu (4.8 million). The National Urban Survey conducted across the metropolitan cities of India reported similar trend: 11.7 per cent in Kolkata (Eastern India), 6.1 per cent in Kashmir Valley (Northern India), 11.6 per cent in New Delhi (Northern India), and 9.3 per cent in West India (Mumbai) compared with (13.5 per cent in Chennai (South India), 16.6 per cent in Hyderabad (south India), and 12.4 per cent Bangalore (South India). Strengthening of health promotion activitiesin different settings, preventive health screening package, better treatment facilities and effective implementation can cure these problems worldwide.
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Thanawala, Uday, Hema Divakar, Rajesh Jain, and Mukesh M. Agarwal. "Negotiating Gestational Diabetes Mellitus in India: A National Approach." Medicina 57, no. 9 (September 6, 2021): 942. http://dx.doi.org/10.3390/medicina57090942.

Повний текст джерела
Анотація:
The worldwide epidemic of diabetes mellitus and hyperglycemia in pregnancy (HIP) presents many challenges, some of which are country-specific. To address these specific problems, parochial resolutions are essential. In India, the government, by working in tandem with (a) national groups such as the Diabetes in Pregnancy Study Group of India, and (b) global organizations such as the International Diabetes Federation, has empowered the medical and paramedical staff throughout the country to manage HIP. Additionally, despite their academic university backgrounds, Indian health planners have provided practical guidelines for caregivers at the ground level, who look up to these experts for guidance. This multipronged process has helped to negotiate some of the multiple problems that are indigenous and exclusive to India. This review traces the Indian journey to manage and prevent HIP with simple, constructive, and pragmatic solutions.
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Kalra, Sanjay, and Mudita Dhingra. "Childhood diabetes in India." Annals of Pediatric Endocrinology & Metabolism 23, no. 3 (September 30, 2018): 126–30. http://dx.doi.org/10.6065/apem.2018.23.3.126.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Viswanathan, Vijay. "Urban diabetes in India." Diabetes Research and Clinical Practice 136 (February 2018): 171–72. http://dx.doi.org/10.1016/j.diabres.2018.01.015.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Joshi, Shashank R. "Diabetes Care in India." Annals of Global Health 81, no. 6 (April 22, 2016): 830. http://dx.doi.org/10.1016/j.aogh.2016.01.002.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Anjana, Ranjit Mohan, Rajendra Pradeepa, Mohan Deepa, Manjula Datta, Vasudevan Sudha, Ranjit Unnikrishnan, Lalith M. Nath, et al. "The Indian Council of Medical Research—India Diabetes (ICMR-INDIAB) Study: Methodological Details." Journal of Diabetes Science and Technology 5, no. 4 (July 2011): 906–14. http://dx.doi.org/10.1177/193229681100500413.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Дисертації з теми "Diabetes in India"

1

Kumar, Alok. "Characterization of Latent autoimmune diabetes in adults in a region of India." Doctoral thesis, Universitat Autònoma de Barcelona, 2018. http://hdl.handle.net/10803/586003.

Повний текст джерела
Анотація:
Introducción: Una proporción de pacientes con diabetes de la edad adulta, que inicialmente no requieren insulina, presentan autoanticuerpos contra la decarboxilasa del ácido glutámico (GADA) en el suero y diferencias fenotípicas con la diabetes clásica tipo 2 (DM2). Se ha propuesto la designación de diabetes autoinmune latente del adulto (LADA) para esta categoría. Objetivos de la investigación: La diabetes autoinmune de la edad adulta es heterogénea. Este hecho ha sido demostrado en Europa y ciertos países no europeos. Los estudios epidemiológicos han encontrado variaciones en la prevalencia de LADA. En el sur de Asia, los datos sobre LADA son escasos. Se ha observado una discrepancia muy marcada en la frecuencia de LADA en la población de la India, entre 2.6% y 58%, que no puede atribuirse a diferencias étnicas o ambientales; más bien a metodologías conflictivas/distintas. El diagnóstico precoz de LADA es importante por sus implicaciones terapéuticas. Con el fin de caracterizar adecuadamente LADA y evaluar su prevalencia real se requiere un criterio de diagnóstico fiable con procedimientos validados. Métodos: Se realizó una investigación transversal en la región norte de la India en 139 sujetos. Los criterios de reclutamiento incluyeron: a) diagnóstico de diabetes; b) edad al diagnóstico, 30-70 años; c) duración conocida de la enfermedad entre 6 meses y 5 años. Se determinaron en muestras de suero/plasma, tras un ayuno de más de 10 horas, las concentraciones de glucosa, hemoglobina glicosilada, perfil lipídico, creatinina, péptido C y GADA. Los pacientes con positividad a GADA insulinizados desde el diagnóstico, o antes de un mes desde el diagnóstico, se definieron como DM1. Los individuos con resultado negativo en la determinación de GADA fueron diagnosticados como DM2. El grupo de sujetos con diabetes y positividad a GADA que no requirieron insulina durante al menos 6 meses tras diagnóstico fueron definidos como LADA. Resultados y Conclusiones: 1- LADA representó el 6.5% de los casos entre las personas adultas con diagnóstico de diabetes, frecuencia considerablemente superior a la informada en estudios previos para esta población. En sujetos diabéticos diagnosticados a los 31-40 años de edad, la frecuencia de LADA fue del 13,9%. El estudio sugirió una tendencia decreciente de LADA con el aumento de edad. 2- LADA fue el subtipo prevalente de diabetes autoinmune de inicio en la edad adulta, dato que convendría contrastar con observaciones previas publicadas de una menor prevalencia de DM-1A entre niños y adolescentes en el norte de la India. En esta población investigada, la prevalencia de LADA fue considerablemente inferior a la informada en el sur de la India. 3- El grupo de sujetos con diagnóstico de LADA es más joven y presenta niveles inferiores de circunferencia abdominal, péptido C sérico y triglicéridos en ayunas, que el grupo de sujetos con DM2 de la misma zona del norte de la India. 4- Los pacientes con LADA con títulos más elevados de GADA en el momento del diagnóstico eran preferentemente varones, más delgados, y necesitaban tratamiento insulínico, presentando menor riesgo de hipertensión sistólica y síndrome metabólico. 5- Los pacientes con LADA con títulos bajos de GADA eran preferentemente mujeres, y no mostraron diferencias fenotípicas con las pacientes con DM-2, en concordancia con datos publicados en la población asiática china, y en contradicción con los publicados para la población europea. 6- En el presente estudio, los niveles séricos de péptido C en ayunas al diagnóstico fueron inferiores en los pacientes LADA que en los pacientes con DM2. Esta diferencia se mantuvo durante 36 meses, contrariamente a los datos del Estudio LADA en España.
Introduction: A significant proportion of diabetic patients with adult‐onset diabetes, initially non requiring insulin treatment, have glutamic decarboxylase autoantibodies (GADA) in their sera and display a different clinical phenotype from classical type 2 diabetes (DM2) without GADA. A new subclass of diabetes with the designation of latent autoimmune diabetes of adult‐onset (LADA) has been proposed for this category of subjects. Research Objectives: Adult-onset autoimmune diabetes is heterogeneous consisting of various groups. This observation has been intensively investigated in Europe and needs a comprehensive search in India. Epidemiological studies have reported varied prevalence of LADA. In South Asia, data on LADA are sparse. Significant discrepancy in the frequency of LADA has been observed in earlier studies on Indian population ranging from 2.6% to 58%. Such variation in the results may be attributed to local differences and conflicting methodology adopted by various authors. Diagnosing LADA early in the disease process is important as it may have therapeutic implications. In order to assess the true prevalence and characterize LADA in various populations, a standardised diagnostic criterion is required. The adoption of standard criterion and valid methods to define LADA would facilitate the rational comparison of the disease between different populations and a more efficient management for all health providers. Methods: We performed a cross-sectional investigation in the Northern region of India that included 139 subjects. Inclusion criteria were: a) diagnosis of diabetes by standard criteria; b) age at diagnosis of diabetes, 30 – 70 years; c) duration of disease between 6 months to 5 years. The concentrations of glucose, glycosylated hemoglobin, lipid profile, creatinine, C-peptide, and GADA were measured in serum/plasma samples after fasting for more than 10 hours. Subjects with GADA in whom insulin was started at diagnosis or within one month of diagnosis were defined as DM1. All antibody negative subjects were diagnosed as DM2. LADA patients were defined as patients who did not require insulin for at least 6 months after diagnosis and depicted GADA at their sera. Results and Conclusions: 1- LADA represents 6.5% of cases among all adult-onset diabetes in a region of Northern India, considerably a higher frequency than reported in two previous studies. In diabetic subjects diagnosed at 31-40 years of age, the frequency of LADA was 13.9%. A decreasing trend of LADA with increasing age was suggested, similar to reports from Chinese and European publications. 2- In our study, LADA was the prevalent subtype of adult-onset autoimmune diabetes, in agreement with earlier reports showing lower prevalence of DM-1A among children and adolescents in Northern India. In this investigated population, the prevalence of LADA was much lower than previously reported in Southern India. 3- The group of subjects with diagnosis of LADA were younger, and presented lower abdominal circumference, serum C-peptide and triglycerides levels at fasting than the group of subjects with DM2 from the same area of Northern India. 4- In our study, LADA patients depicting high titers of GADA in their sera at the time of diagnosis were more likely to be male, leaner, and insulin- treated, and less likely to display systolic hypertension and the metabolic syndrome. 5- In the same investigated population, LADA patients depicting low titers of GADA in their sera were mostly females, and they did not show phenotypic differences than DM-2 patients, similar to data reported for Asian Chinese population, in contradiction to the data reported for European population. 6- In comparison to subjects with DM2, serum C-peptide levels at fasting at the time of diagnosis were lower in LADA patients in the current study. This difference remained after 36 months, contrary to data of Spanish LADA Study.
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Chaudhry, Chhaya S. "Emerging Diabetes Pandemic in India: A Case Study for an Integrative Approach." ScholarWorks, 2011. http://scholarworks.waldenu.edu/dissertations/1176.

Повний текст джерела
Анотація:
Every day, India sees the addition of 5,000 new cases of diabetes to its current diabetic population of 65 million people. This number is projected to cross the 100 million mark in 15 years. The emerging pandemic scale of diabetes growth is straining India's already-overburdened public healthcare resources. India is home to several well-established native and adapted foreign traditions of medicine that are widely practiced. These traditions include Ayurveda, yoga and naturopathy, unani, siddha, and homeopathy. The modern and traditional medicine approaches are extensively used as independent systems. The purpose of this qualitative research case study was to evaluate the use of an integrative approach to address the multiple challenges posed by diabetes in India. The research design for the case study was based on the theoretical framework of participatory action research. The research questions evaluated how the modern and traditional medicine systems can be jointly used to contain the spread, scale, and immensity of diabetes in India and examined the barriers and challenges in combining various systems of medicine. Data were collected from interviews with 30 modern and traditional medical practitioners and 6 policy makers identified through a stratified purposeful sampling process. The transcribed data were coded thematically and objectively analyzed. The trustworthiness of interpretations was bolstered with triangulation through records from notes and observations. In evaluating the feasibility of a synergistic and integrative approach, the study filled a gap in scholarly literature. The study contributes to social change by adding to the existing body of knowledge available to physicians and patients in preventing and containing the diabetes pandemic.
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Chaudhry, Chhaya S. "Emerging Diabetes Pandemic in India| A Case Study for an Integrative Approach." Thesis, Walden University, 2014. http://pqdtopen.proquest.com/#viewpdf?dispub=3665809.

Повний текст джерела
Анотація:

Every day, India sees the addition of 5,000 new cases of diabetes to its current diabetic population of 65 million people. This number is projected to cross the 100 million mark in 15 years. The emerging pandemic scale of diabetes growth is straining India's already-overburdened public healthcare resources. India is home to several well-established native and adapted foreign traditions of medicine that are widely practiced. These traditions include Ayurveda, yoga and naturopathy, unani, siddha, and homeopathy. The modern and traditional medicine approaches are extensively used as independent systems. The purpose of this qualitative research case study was to evaluate the use of an integrative approach to address the multiple challenges posed by diabetes in India. The research design for the case study was based on the theoretical framework of participatory action research. The research questions evaluated how the modern and traditional medicine systems can be jointly used to contain the spread, scale, and immensity of diabetes in India and examined the barriers and challenges in combining various systems of medicine. Data were collected from interviews with 30 modern and traditional medical practitioners and 6 policy makers identified through a stratified purposeful sampling process. The transcribed data were coded thematically and objectively analyzed. The trustworthiness of interpretations was bolstered with triangulation through records from notes and observations. In evaluating the feasibility of a synergistic and integrative approach, the study filled a gap in scholarly literature. The study contributes to social change by adding to the existing body of knowledge available to physicians and patients in preventing and containing the diabetes pandemic.

Стилі APA, Harvard, Vancouver, ISO та ін.
4

Affan, Eshan Tahrir. "Diabetes and lipid levels in Rural Andhra Pradesh, India - 2005 to 2014." Thesis, The University of Sydney, 2015. http://hdl.handle.net/2123/14056.

Повний текст джерела
Анотація:
Background Rural Andhra Pradesh is a developing region in India with reported high prevalence of diabetes mellitus and blood lipid levels. This is consistent with a worldwide transition of mortality and morbidity towards predominantly non-communicable conditions such as heart disease, stroke and diabetes. Detecting and monitoring these changes in less accessible regions of the world is a difficult task. Methods Three cross sectional studies examining cardiovascular risk factors in the Godavari region of rural Andhra Pradesh were done in 2005 (Andhra Pradesh Rural Health Initiative, APRHI), 2010 (Gates Grand Challenge 13, GC13) and 2014 (Systematic Medical Appraisal Referral and Treatment Health, SMARThealth). Diabetes prevalence from all three studies and blood lipid levels from 2005 and 2010 were compared to assess the trend. The data were further divided into a primary analysis including only fasting plasma glucose measurements and a secondary analysis which allowed for other methods of diabetes diagnosis. A systematic review and meta-analysis of the use of dried blood spots (DBS) for cardiometabolic risk factor analysis was also conducted. Findings Sixteen studies were included in the meta-analysis of the use of dried blood spots, 12 of which reported necessary data for haemoglobin A1c (HbA1c), one for triglycerides, two for both triglycerides and total cholesterol and one for HbA1c, total cholesterol and high density lipoprotein (HDL). Study sizes ranged from 30 to 613 participants. For HbA1c the summary regression (DBS = 0.9858Venous + 0.3809) showed close agreement between analyses based upon the venous and DBS sampling methods. The summary regression line for total cholesterol (DBS = 0.6807Venous + 1.151) indicates a requirement for moderate adjustment of values based upon analyses of DBS samples to obtain estimates equivalent to standard analyses based upon venous samples. For triglycerides, the summary regression for the three contributing studies showed a close association between the results obtained for the two methods (DBS = 0.9557Venous + 0.1427). The primary analyses of dysglycaemia (diabetes and prediabetes) were based upon 3243 individuals from APRHI and 749 individuals from SMARThealth for whom fasting plasma glucose samples were available. The estimated prevalence of dysglycaemia was 53.7% (51.8 - 55.7, 95% CI) in 2005 and 62.0% (58.5 - 65.4, 95% CI) in 2014 (p<0•001). The primary difference in population characteristics across the two surveys was a more than one unit rise in mean BMI driven by an approximate 1.7kg rise in mean weight. For the secondary analyses there were 3333 individuals aged 40 to 85 included from the APRHI study in 2005; 2200 individuals included from the GC13 survey done in 2010; and 62 254 participants included from the SMARThealth survey in 2014. For the secondary analyses the estimated prevalence of dysglycaemia was 53•9% (52•0 - 55•9, 95% CI) in 2005, 50•5% (46.1 - 54.9, 95% CI) in 2010, and 41.3% (40.9 - 41.7, 95% CI) in 2014 with the data suggesting a decline across the three time points (p<0.001). There were significant increases observed between 2005, 2010, and 2014 for both body mass index (BMI) (p<0.001) and weight (p<0.001). Mean total cholesterol decreased from 4.6mM in 2005 to 3.4mM in 2010 while mean low density lipoprotein decreased from 2.9mM to 1.5mM during the same period. Conclusions The use of dried blood spots as a method of reporting HbA1c levels appears justified but further studies are required to confirm the suitability of blood lipid level measurements based upon dried blood spots. Every estimate of dysglycaemia was high suggesting that dysglycaemia is a major problem in this part of Andhra Pradesh. Further, the upward trend in dysglycaemia observed in the primary analyses and the corresponding adverse trend in obesity measures suggests that the problem is getting worse not better. The differences in observed trends between the primary and secondary analyses are almost certainly attributable to the variable assay methods used across the data included in the secondary analyses. The steep changes in lipid levels are likely incorrect and have been biased by the study methods.
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Chaudhry, Chhaya Sanjeev. "Emerging Diabetes Pandemic in India: A Case Study for an Integrative Approach." ScholarWorks, 2014. https://scholarworks.waldenu.edu/dissertations/54.

Повний текст джерела
Анотація:
Every day, India sees the addition of 5,000 new cases of diabetes to its current diabetic population of 65 million people. This number is projected to cross the 100 million mark in 15 years. The emerging pandemic scale of diabetes growth is straining India's already-overburdened public healthcare resources. India is home to several well-established native and adapted foreign traditions of medicine that are widely practiced. These traditions include Ayurveda, yoga and naturopathy, unani, siddha, and homeopathy. The modern and traditional medicine approaches are extensively used as independent systems. The purpose of this qualitative research case study was to evaluate the use of an integrative approach to address the multiple challenges posed by diabetes in India. The research design for the case study was based on the theoretical framework of participatory action research. The research questions evaluated how the modern and traditional medicine systems can be jointly used to contain the spread, scale, and immensity of diabetes in India and examined the barriers and challenges in combining various systems of medicine. Data were collected from interviews with 30 modern and traditional medical practitioners and 6 policy makers identified through a stratified purposeful sampling process. The transcribed data were coded thematically and objectively analyzed. The trustworthiness of interpretations was bolstered with triangulation through records from notes and observations. In evaluating the feasibility of a synergistic and integrative approach, the study filled a gap in scholarly literature. The study contributes to social change by adding to the existing body of knowledge available to physicians and patients in preventing and containing the diabetes pandemic.
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Hill, Jacqueline Charlotte. "Glucose tolerance and insulin status during pregnancy in South India : relationships to maternal and neonatal body composition." Thesis, University of Southampton, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.326396.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Thankappan, K. R., G. K. Mini, Meena Daivadanam, G. Vijayakumar, P. S. Sarma, and Mark Nichter. "Smoking cessation among diabetes patients: results of a pilot randomized controlled trial in Kerala, India." BioMed Central, 2013. http://hdl.handle.net/10150/610095.

Повний текст джерела
Анотація:
BACKGROUND:India has the second largest diabetic population (61 million) and tobacco users (275 million) in the world. Data on smoking cessation among diabetic patients are limited in low and middle income countries. The objective of the study was to document the effectiveness of diabetic specific smoking cessation counseling by a non-doctor health professional in addition to a cessation advice to quit, delivered by doctors.METHODS:In our parallel-group randomized controlled trial, we selected 224 adult diabetes patients aged 18 years or older who smoked in the last month, from two diabetes clinics in South India. Using a computer generated random sequence with block size four
the patients were randomized equally into intervention-1 and intervention-2 groups. Patients in both groups were asked and advised to quit smoking by a doctor and distributed diabetes specific education materials. The intervention-2 group received an additional diabetes specific 30 minutes counseling session using the 5As (Ask, Advise, Assess, Assist and Arrange), and 5 Rs (Relevance, Risks, Rewards, Roadblocks and Repetition) from a non-doctor health professional. Follow up data were available for 87.5% of patients at six months. The Quit Tobacco International Project is supported by a grant from the Fogarty International Centre of the US National Institutes of Health (RO1TW005969-01).The primary outcomes were quit rate (seven day smoking abstinence) and harm reduction (reduction of the number of cigarettes / bidis smoked per day > 50% of baseline use) at six months.RESULTS:In the intention to treat analysis, the odds for quitting was 8.4 95% confidence interval (CI): 4.1-17.1] for intervention-2 group compared to intervention-1 group. Even among high level smokers the odds of quitting was similar. The odds of harm reduction was 1.9 (CI: 0.8-4.1) for intervention-2 group compared to intervention-1 group.CONCLUSIONS:The value addition of culturally sensitive diabetic specific cessation counseling sessions delivered by non-doctor health professional was an impressive and efficacious way of preventing smoking related diabetic complications.TRIAL REGISTRATION:Clinical Trial Registry of India (CTRI/2012/01/002327)
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Stein, Claudia Elisabeth. "Coronary heart disease, diabetes, serum lipid concentrations and lung function in relation to fetal growth in south India." Thesis, University of Southampton, 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.242673.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Helmersson, Anna, and Anna Wellton. ""It is all together, like the five fingers in our hand. Everything is needed." : Nursing care provided to patients with type 2 diabetes at an Indian diabetes clinic." Thesis, Röda Korsets Högskola, 2013. http://urn.kb.se/resolve?urn=urn:nbn:se:rkh:diva-768.

Повний текст джерела
Анотація:
Background: Type 2 diabetes is among the fastest growing diseases in the world, especially in India where the prevalence is 9 percent and expected to rise significantly. Managing diabetes involves a substantial portion of self-care and lifestyle changes for the patient. Hence, the nursing care to patients needs to be focused on promoting self-care and empowerment. Objective: To describe the nursing care, focusing on self-care and empowerment, provided to patients with type 2 diabetes at a private diabetes clinic in India. Method: Eleven diabetes educators with specialist training were interviewed individually. Data was analysed using qualitative contents analysis. Results: One core category called Comprehensive approach was found. Additionally, the data was sorted into four main categories: Nursing care interventions, Counselling, Health education and Health protection. Conclusion: The participants had a comprehensive view of the patients, the disease and the role of health personnel involved in the care. This holistic approach permeated the nursing care performed by the participants, facilitated empowerment and the promotion of self-care to the patients. Clinical relevance: The study provides a widened perspective and understanding of the concepts of self-care and empowerment to patients with type 2 diabetes in different cultural contexts. The results can serve as an inspiration to new ways of promoting self-care and empowerment to patients with other health problems.
Bakgrund: Diabetes typ 2 är en av de snabbast ökande sjukdomarna i världen, särskilt i Indien. Där är prevalensen 9 procent och den befaras stiga betydligt. För att hantera sjukdomen behöver patienten genomföra livsstilsförändringar och behärska egenvård. Därför bör omvårdnaden inriktas på empowerment och att främja patientens förmåga till egenvård. Syfte: Att beskriva den omvårdnad, med fokus på egenvård och empowerment, som ges till patienter med diabetes typ 2 på en specialistklinik i Indien. Metod: Elva diabetesutbildare med specialistutbildning intervjuades individuellt. Materialet analyserades med hjälp av kvalitativ innehållsanalys. Resultat: En kärnkategori, kallad Helhetsperspektiv, hittades. Därutöver sorterades materialet in i fyra huvudkategorier: Omvårdnadsåtgärder, Rådgivning, Hälsoutbildning och Hälsoskyddande åtgärder. Slutsats: Respondenterna hade en helhetssyn på patienterna och sjukdomen, samt på den roll all hälsopersonal som var inblandad i vården hade. Denna helhetssyn genomsyrade omvårdnaden, hur respondenterna arbetade med empowerment till patienterna samt hur de stärkte patienternas kapacitet att utföra egenvård. Klinisk betydelse: Studien bidrar till en vidgad syn på och ökad förståelse för begreppen egenvård och empowerment när det gäller patienter med diabetes typ 2 i olika kulturella kontexter. Resultatet kan även inspirera till nya sätt att arbeta med empowerment och att främja egenvård bland andra patientgrupper.
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Johansson, Linn, and Angelika Johansson. "Nurses experience of applying professional competence and influencing the quality of nursing care in terms of diabetes in an Indian rural hospital - an interview study." Thesis, Karlstads universitet, Institutionen för hälsovetenskaper, 2015. http://urn.kb.se/resolve?urn=urn:nbn:se:kau:diva-35926.

Повний текст джерела
Анотація:
Introduction - India is beginning to resemble the western worlds’ way of living and that leads to an increased risk of chronic diseases such as diabetes. Due to its very large population India has the world second largest number of people with diabetes; 61, 3 million people. Studies have shown that the awareness of diabetes is poor, especially in rural areas. Aim - To investigate nurses’ experience of applying professional competence in patient education with focus on diabetes type II in an Indian rural hospital. Method – Data was gathered through twelve qualitative interviews. The interviews were tape recorded, transcribed verbatim and then analyzed through content analysis. Result – Three main categories were identified; Acquired competence to meet the patients, Helping the patients manage their disease and Nurses’ ideas for quality improvements regarding diabetes care. Conclusion - This study identified different obstacles that could have a negative effect on the care and treatment of patients with diabetes type II. The nurses had many ideas for quality improvements which could raise the awareness of the disease among patients, improve clinical outcomes and the work environment for the nurses. The nurses are willing to get more education about the disease and implement quality improvements if the resources and equipment are provided by the hospital.
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Книги з теми "Diabetes in India"

1

V, Balakrishnan, Kumar Harish, S. Sudhindran, and A. G. Unnikrishnan. Chronic pancreatitis and pancreatic diabetes in India. Edited by Indian Pancreatitis Study Group. Cochin, India]: Indian Pancreatitis Study Group, 2006.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Mukherjee, S. K. Progress of diabetes research in India during 20th century. New Delhi: National Institute of Science Communication, 2002.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

India) National Diabetes Summit -- "Preventing and Combating Diabetes Across the Nation" (2014 New Delhi. Rising burden of diabetes in India: Challenges and solutions. New Delhi: The Associated Chambers of Commerce and Industry of India, 2014.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

India-USA Symposium on Endocrinology, Metabolism, and Diabetes--"EMD 1990" (1990 All India Institute of Medical Sciences). Advances in endocrinology, metabolism, and diabetes: Proceedings of the India-USA Symposium on Endocrinology, Metabolism, and Diabetes--"EMD 1990"). Edited by Kochupillai N. New Delhi: Macmillan India, 1992.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

International Conference on "Diabetes and Nutrition: a South Asian Perspective" (2000 Velha Goa, "India). Epidemiology and determinants of type 2 diabetes in South Asian countries: Bangladesh, India, Nepal, and Sri Lanka. New Delhi: ILSI-India, 2000.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Gupta, Indrani. Potential impact on health and economic inequality from cardiovascular diseases and diabetes in India: Evidence from the national sample survey. Delhi: Institute of Economic Growth, 2009.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Mehta, Deepa. Speaking of diabetes and diet. New Delhi: Sterling Publishers Private, 1991.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Mehta, Deepa. Speaking of diabetes and diet. New Delhi: Sterling, 2002.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Lite and luscious cuisine of India: Recipes and tips for healthy and quick meals. Ames, Iowa: Piquant Publishing, 1997.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Asian Network of Research on Antidiabetic Plants. International Seminar. Diabetes mellitus epidemic, combat the challenge: Proceeding of the 4th International Seminar of Asian Network of Research on Antidiabetic Plants (ANRAP), January 16-18, 2004, Hotel Sonar Bangla Sheraton, Kolkata, India. Edited by Mukherjee Biswapati, Debnath Pratip Kumar 1946-, Biswas Tuhin Kanti 1964-, Chakrabarti Shrabana 1975-, Banerjee Shivaji 1964-, and Asian Network of Research on Antidiabetic Plants. New Delhi: Tata McGraw-Hill Pub. Co., 2005.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Частини книг з теми "Diabetes in India"

1

Viswanathan, V. "Recent International Developments: India." In The Foot in Diabetes, 375–78. Chichester, UK: John Wiley & Sons, Ltd, 2006. http://dx.doi.org/10.1002/0470029374.ch33.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Joshi, Shashank R., and S. R. Aravind. "Diabetes in India and Southeast Asia." In Diabetes Mellitus in Developing Countries and Underserved Communities, 85–100. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-41559-8_6.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Misra, Parimal, and Ranjan Chakrabarti. "Introduction to Diabetes and Prevalence in India." In Drug Discovery and Drug Development, 159–63. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-15-8002-4_6.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Mohan, V., V. Sudha, G. Radhika, V. Radha, M. Rema, and R. Deepa. "Gene-Environment Interactions and the Diabetes Epidemic in India." In Nutrigenomics - Opportunities in Asia, 118–26. Basel: KARGER, 2007. http://dx.doi.org/10.1159/000107088.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Pal, Sarbani, and Manojit Pal. "Anti-diabetes Research in India: Contributions from Industrial Organizations." In Drug Discovery and Drug Development, 179–212. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-15-8002-4_8.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Raja Rajeswari, P., Chandrasekaran Subramaniam, and Allam Appa Rao. "Diversified Insulin-Associated Beta-Behavioral and Endogenously Triggered Exposed Symptoms (DIABETES) Model of Diabetes in India." In SpringerBriefs in Applied Sciences and Technology, 1–15. Singapore: Springer Singapore, 2014. http://dx.doi.org/10.1007/978-981-287-338-5_1.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Khandelwal, Shweta. "Malnutrition and COVID-19 in India." In Health Dimensions of COVID-19 in India and Beyond, 171–201. Singapore: Springer Singapore, 2022. http://dx.doi.org/10.1007/978-981-16-7385-6_9.

Повний текст джерела
Анотація:
AbstractWhile the world is battling the new coronavirus known as SARS-COV-2, public health and nutrition services in India are getting disrupted and derailed. It is pertinent not to overlook the existing gaps in our journey towards attaining the holistic sustainable development goals (SDGs). In fact, it is now well-established that comorbidities, especially malnutrition, diabetes, cardiovascular diseases, and other respiratory or kidney problems exacerbate the pathogenesis of COVID-19 because of an already compromised immune system. The whole world is off track in achieving SDG 2, known as Zero Hunger, by 2030. At the current pace, approximately 17 countries including India will fail to even reach low hunger by 2030. India ranks 104 out of 117 countries as per the used metric, the global hunger index. Furthermore, these projections do not account for the impact of the COVID-19 pandemic, which may worsen hunger and undernutrition in the near term and affect countries’ trajectories into the future.The author underscores the serious adverse impacts of COVID-19 on public health, nutrition, and food security in India and other low- and middle-income countries. Estimates show that 135 million persons were hungry before the pandemic. By the end of 2020, the number will likely increase to 265 million. India carries a heavy burden of multiple forms of malnutrition including undernutrition, hunger, micronutrient deficiencies as well as overweight, and obesity. India’s public health and nutritional policies must urgently address these problems. Measures taken by the government during the pandemic to counter its negative impact on the nutrition of women, children, migrant labor, and other vulnerable populations are enumerated. The response of the international community to tackle COVID-19 related nutritional challenges and India’s policy measures for ensuring nutrition and food security are discussed.
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Reddy, A. Madhusudhana, and C. Nagendra. "Ethnobotanical Information of Medicinal Plants Used for Diabetes Mellitus in Seshachalam Biosphere Reserve, Andhra Pradesh, India." In Antidiabetic Potential of Plants in the Era of Omics, 153–69. New York: Apple Academic Press, 2022. http://dx.doi.org/10.1201/9781003282860-8.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Moorthy, Aditya, and Shreya Krishna. "Management of Medical Comorbidities in Maxillofacial Surgery." In Oral and Maxillofacial Surgery for the Clinician, 25–48. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-15-1346-6_3.

Повний текст джерела
Анотація:
AbstractOral and Maxillofacial surgery, like any surgical specialty, has two vital requirements. First, having the right armamentarium, and, second, acquiring appropriate skills and knowledge of the patients’ disease process, including comorbidities. With the changing demographic in India, the profile of Indian patient has undergone a sea change in the last few decades. From acute conditions that had little impact on subsequent health of the patient, we have arrived at a scenario where a large proportion of patients present with chronic disorders like diabetes, ischemic heart diseases, etc. that affect many elective procedures we undertake and require optimization of the overall physical status of the patient before proceeding with any surgery.Trainee surgeons need to be aware and updated and should be able to recognize, treat, or appropriately refer patients to the requisite specialty in case of complex conditions beyond their remit or ability. In this chapter, readers will get a very brief overview of the different organ systems that play crucial role in homeostasis and how to modify the treatment when there’s an imbalance in either of these systems.
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Naidu, M. Tarakeswara, S. Suthari, O. Aniel Kumar, and M. Venkaiah. "Ethno-botanico-medicine in the Treatment of Diabetes by the Tribal Groups of Visakhapatnam District, Andhra Pradesh, India." In Medicinal Plants: Biodiversity, Sustainable Utilization and Conservation, 195–203. Singapore: Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-1636-8_10.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "Diabetes in India"

1

Roy, Mr Mrinmoy, and Dr Mohit Jamwal. "The Advent of Artificial Intelligence in Diabetes Diagnosis: Current Practices and Building Blocks for Future Prospects." In 2nd International Conference on Public Health and Well-being. iConferences (Pvt) Ltd, 2022. http://dx.doi.org/10.32789/publichealth.2021.1008.

Повний текст джерела
Анотація:
India has the highest proportion of diabetes patients, and it is estimated that there will be 134 Million diabetics in India by 2045 as per IDF. Also, the disease burden is increasing to the young population between ages 25-40 as more of them are diagnosed positive according to JAMA recently. Moreover, there are only 4.8 Doctors per 10,000 population, and in villages, the ratio is the lowest possible in this country, according to the Indian Journal of Public Health. Therefore, screening & predicting Diabetes at an early stage remains a priority for clinicians. It reduces the risk of major complications and improves patients' quality of life with diabetes, and builds resilience and well-being amongst other citizens. With the advancement of Computer Science & Artificial Intelligence, it is now possible to predict diabetes and other such diseases through applying deep learning algorithms in high-quality data sets. This helps in a more accurate and faster diagnosis of Pre-diabetes, Diabetes & diabetes-related progressive eye diseases. In this study, a systematic review of the Pubmed repository for current practices to diagnose Diabetes based on AI intervention in the Indian context is carried out. Also, a critical analysis was done on various pioneered companies currently offering AI-based Diabetes diagnostic services in India. The study represents different concepts of AI tools used to predict the diseases currently available in India. Although most of the studies were carried out on Diabetic Retinopathy screening, future opportunities can be in several other areas such as Clinical Decision Support, Predictive Population Risk Stratification and Patient Self-Management Tools.
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Srivatsan, Shruti, and T. Santhanam. "Application of ensemble classifiers for early diabetes detection." In 2021 Grace Hopper Celebration India (GHCI). IEEE, 2021. http://dx.doi.org/10.1109/ghci50508.2021.9514027.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Chandrakar, Omprakash, and Jatinderkumar R. Saini. "Development of Indian Weighted Diabetic Risk Score (IWDRS) using Machine Learning Techniques for Type-2 Diabetes." In ACM COMPUTE '16: Ninth Annual ACM India Conference. New York, NY, USA: ACM, 2016. http://dx.doi.org/10.1145/2998476.2998497.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Ranjeeth, S., Venkata Ajay Krishna Kandimalla, and Gangadhar Reddy D. "Predicting Diabetes Using Outlier Detection and Multilayer Perceptron with Optimal Stochastic Gradient Descent." In 2020 IEEE India Council International Subsections Conference (INDISCON). IEEE, 2020. http://dx.doi.org/10.1109/indiscon50162.2020.00023.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Cheruku, Ramalingaswamy, and Damodar Reddy Edla. "Bin-BB: Binning with Branch & Bound feature selection for improved diabetes classification." In 2017 14th IEEE India Council International Conference (INDICON). IEEE, 2017. http://dx.doi.org/10.1109/indicon.2017.8487868.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Kalita, Deepjyoti, and Khalid B. Mirza. "Physical Activity Classification with Smartphone based Accelerometer, Gyroscope and Device Motion for Personal Diabetes Healthcare Management." In 2022 IEEE 19th India Council International Conference (INDICON). IEEE, 2022. http://dx.doi.org/10.1109/indicon56171.2022.10039967.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Tyagi, Khushali, Deepak Kumar, and Richa Gupta. "Application of Genetic Algorithm to optimize the Age-wise and Gender-wise growth of diabetes population in India." In 2022 International Conference on Machine Learning, Big Data, Cloud and Parallel Computing (COM-IT-CON). IEEE, 2022. http://dx.doi.org/10.1109/com-it-con54601.2022.9850785.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Bigyananda Meitei, Wahengbam. "District Level Assessment of Spatial Clustering and Determinants of Diabetes Mellitus among Older Adolescents and Young Adults in India." In The International Conference on Public Health and Well-being. iConferences, 2019. http://dx.doi.org/10.32789/publichealth.2019.1003.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Selander, Jenny, Johanna Jonsson, Claudia Lissåker, Per Gustavsson, Pernilla Wiebert, Maria Albin, Lars Alfredsson, and Jenny Selander. "P-292 Occupational exposure to chemicals and particles during pregnancy and associations with gestational hypertension, preeclampsia and gestational diabetes." In 29th International Symposium on Epidemiology in Occupational Health (EPICOH 2023), Mumbai, India, Hosted by the Indian Association of Occupational Health, Mumbai Branch & Tata Memorial Centre. BMJ Publishing Group Ltd, 2023. http://dx.doi.org/10.1136/oem-2023-epicoh.237.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

B Theruvan, Neethu, and Jaimy M Jose. "Evaluate the efficacy of Pranayama (alternate nostril breathing exercise) in reducing perceived symptom experiences among type 2 diabetes mellitus patients at India." In Annual Worldwide Nursing Conference. Global Science & Technology Forum (GSTF), 2014. http://dx.doi.org/10.5176/2315-4330_wnc14.76.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Звіти організацій з теми "Diabetes in India"

1

Goldman Rosas, Lisa, Jan Vasquez, Nan Lv, Lan Xiao, Haley Hedlin, FeiFei Qin, Adrian Kendrick, Dawn Atencio, and Randall Stafford. Comparing Two Diabetes Prevention Programs for American Indian and Alaska Native Adults in an Urban Community. Patient-Centered Outcomes Research Institute (PCORI), July 2020. http://dx.doi.org/10.25302/07.2020.ad.130602172.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

New sub-groups of diabetes could lead to more targeted treatment for people in India. National Institute for Health Research, March 2021. http://dx.doi.org/10.3310/alert_45105.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Також вас можуть зацікавити розширені добірки на тему "Diabetes in India" для конкретних типів джерел:
Статті в журналах Дисертації Книги
Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!

До бібліографії